Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alcohol dehydrogenase 5 (class III), chi polypeptide pseudogene (ADH5P1) is a non-coding sequence in the human genome related by sequence to the ADH5 gene family. Pseudogenes are genomic DNA sequences similar to known genes but non-functional due to mutations, deletions, or premature stop codons. This pseudogene shares similarity with the coding region of ADH5, but due to frameshifts and internal stop codons, it cannot produce a functional enzyme. Unlike its parental gene ADH5, which plays a role in formaldehyde and alcohol metabolism, the pseudogene lacks biological or pharmacological functionality and is not considered in drug development or clinical diagnostics.
None (does not have a pharmacological mechanism)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alcohol dehydrogenase 5 (class III), chi polypeptide pseudogene (ADH5P1).